Introduction {#Sec1}
============

Observational studies potentially suffer from confounding. Propensity score methods, first introduced by Rosenbaum and Rubin \[[@CR1]\], are increasingly being used in medical research to handle confounding \[[@CR2]--[@CR5]\]. When the observed baseline characteristics are sufficient to correct for confounding bias and the propensity model is correctly specified, propensity score analysis creates conditional exchangeability between persons with the same propensity score. Numerous studies provide illustrations and discussions on the performance of different propensity score approaches \[[@CR3], [@CR4], [@CR6]--[@CR11]\].

Besides confounding, observational studies often have missing values in covariates. Missing values can occur by different mechanisms: values are *missing completely at random* (MCAR) when the probability that a value is missing is independent from observed and unobserved information (e.g. a lab measurement is missing, because a technician dropped a tube), *missing at random* (MAR) where the probability of missing depends only on observed information (e.g. lab measurements are only performed when other measured variables were abnormal), or *missing not at random* (MNAR) where the probability of missing depends on unobserved information (e.g. lab measurements are only performed when a doctor judged that a patient was in a severe condition, while the severity is not well-registered.) \[[@CR12]\]. However, it is difficult to decide on the type of missing mechanism, especially when distinguishing whether the data are *missing at random* or *not at random* \[[@CR13], [@CR14]\]. Especially in routinely collected data, variables are often selectively measured based on a patient's characteristics which are often not well-specified \[[@CR15]\]. If those ill-defined characteristics are associated with the variable with missing values, data is missing not at random. External knowledge or assumptions about the clinical setting are required to distinguish whether the missing is at random or not at random.

How to estimate propensity scores when there are missing values is a challenge when studying causal associations \[[@CR16]\]. There are different strategies to handle missing data in a propensity score analysis. The simplest approach is to discard all observations with missing data, a so-called complete case analysis \[[@CR12], [@CR17]\]. Including a missing indicator in a statistical model is another simple method. However, various studies showed that the method in general introduce bias \[[@CR18]--[@CR21]\]. Multiple imputation is a standard method to deal with missing data. Many studies have shown the advantage of multiple imputation and its superiority over other methods \[[@CR12], [@CR19], [@CR22]\]. In combination with propensity scores, however, several questions arise: Should we include the outcome in the imputation model? Can we use the imputation methods implemented in standard software? How should we combine the results of the different propensity scores estimated in each imputed dataset?

The aim of this simulation study is to investigate how different strategies of handling missing values of covariates in a propensity score model can yield valid causal treatment effect estimates. To limit the scope of the study, we deal only with missing values in the baseline characteristics, which is a rather common situation happens in routinely collected data. We create simulation scenarios varying in their missing data mechanisms, presence of heterogeneous treatment effect and unmeasured confounding. Subsequently, the results are used to provide guidance in choosing an optimal strategy to handle missing data in the context of propensity score analysis.

Simulation description {#Sec2}
======================

We generated simulated data with missing values in one of the confounders and compared effect estimates obtained by using several different strategies to deal with missing data. In Sect. [2.1](#Sec3){ref-type="sec"} we considered a situation without unmeasured confounding and with the equal treatment effect for all subjects. In Sect. [2.2](#Sec4){ref-type="sec"}, we introduced a heterogeneous treatment effect. In Sect. [2.3](#Sec5){ref-type="sec"}, the simulations were extended by adding unmeasured confounding.

Simulation setting 1: No unmeasured confounding and a homogeneous treatment effect {#Sec3}
----------------------------------------------------------------------------------

In this simulation series, for each subject we generated two continuous covariates X~1~ and X~2~. X~1~ follows a normal distribution of mean 0 and standard deviation of 1. X~2~ depended on X~1~, where for subject *i*,$$\documentclass[12pt]{minimal}
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Missingness-graphs (*m*-graph, for short) of each missing scenario are depicted in Fig. [1](#Fig1){ref-type="fig"}. The missingness graph is a graphical tool to represent missing data, proposed by Mohan et al. \[[@CR23]\]. Guidance for practical users is given in Thoemmes and Mohan \[[@CR24]\]. These graphs are extensions to causal directed acyclic graphs (DAGs) where nodes indicate covariates and arrows indicate causal relations. When a covariate contains missing values (X~2~ in our simulations), it is expressed by a dashed rectangle around the node. The node R represents the missingess of X~2~, and can be referred to as a missing indicator of X~2~. The observed portion of X~2~ is represented as X~2~\*. When R = 0, X~2~\* is identical to X~2~, and when R = 1, X~2~\* is missing. In our simulations we restricted ourselves to the situation where missing values occur only in one covariate. However, *m*-graphs can be extended to situations with multiple covariates having missing values and, accordingly, with multiple missing indicator variables.Fig. 1M-graphs for Simulation setting 1: MCAR scenario (**a**), MAR scenario (**b**), and MANR scenario (**c**)

Simulation setting 2: No unmeasured confounding and a heterogeneous treatment effect {#Sec4}
------------------------------------------------------------------------------------

The setup of this simulation series is the same as in Simulation setting 1, but here we assumed effect modification by X~2~. That is,$$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{array}{*{20}c} {{\text{Y}}_{i} = {\text{X}}_{1i} + {\text{X}}_{2i} + {\text{T}}_{i} {\text{X}}_{2i} + \varepsilon_{i} ,\quad {\text{with}}\; \varepsilon_{i} \,\sim\,N\left( {0,1} \right)} \\ \end{array}$$\end{document}$$The average treatment effect in the population was equal to null as in Simulation setting 1. However, due to the effect modification by X~2~, the average treatment effect was negative for subjects with X~2~ \< 0 and positive for subjects with X~2~ \> 0. Missing values were generated in the X~2~ variable, following the same mechanisms as in Simulation setting 1. The *m*-graphs for each scenario are depicted in Fig. [2](#Fig2){ref-type="fig"}. In these m-graphs, there is an arrow from the treatment assignment (T) to the outcome (Y), because for some subjects the treatment has an effect on their outcome.Fig. 2M-graphs for Simulation setting 2: MCAR scenario (**a**), MAR scenario (**b**), and MANR scenario (**c**)

Simulation setting 3: Unmeasured confounding and a homogeneous treatment effect {#Sec5}
-------------------------------------------------------------------------------

In this series of simulations, we assumed an additional unobserved confounder U, normally distributed with a mean of 0 and standard deviation of 1 and independent from X~1~. X~2~ depended on X~1~ and U, where for subject *i*,$$\documentclass[12pt]{minimal}
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                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$\begin{array}{*{20}c} {logit\left( {P\left( {T_{i} = 1 | {\text{X}}_{1i} , {\text{X}}_{2i} ,{\text{U}}_{i} } \right)} \right) = - 0.85 + 0.5 {\text{X}}_{1i} + 0.5 {\text{X}}_{2i} + 0.5 {\text{U}}_{i} } \\ \end{array}$$\end{document}$$In this way about 33% of the generated subjects received the treatment. The outcome now depended on X~1~, X~2~ and U:$$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{array}{*{20}c} {{\text{Y}}_{i} = {\text{X}}_{1i} + {\text{X}}_{2i} + {\text{U}}_{i} + \varepsilon_{i} , \quad {\text{with }}\;\varepsilon_{i} \,\sim\,N\left( {0,1} \right)} \\ \end{array}$$\end{document}$$Here, we assumed a homogeneous treatment effect which was set to null. We considered two missing scenarios for X~2~; one according to the MCAR mechanism and the other MNAR mechanism.A MCAR scenario: 50% of values are randomly set to be missing in X~2.~A MNAR scenario: Here we considered a common situation in routinely collected health care data where the missing of X~2~ depended on the unobserved confounder U. We set the value of X~2~ to be missing if U \> 0.

A MAR scenario was not considered in this simulation setting. This is because we were interested in comparing a situation where an unmeasured confounder U affect the missingness of X~2~ (MNAR) to a situation where it does not affect the missingness of X~2~ (MCAR). The m-graphs for these scenarios are illustrated in Fig. [3](#Fig3){ref-type="fig"}.Fig. 3M-graphs for Simulation setting 3: MCAR scenario (**a**), MNAR scenario (**b**)

Analysis of the simulated datasets {#Sec6}
----------------------------------

In every simulated dataset, we estimated propensity scores by logistic regression. The treatment effect was estimated by (1) propensity matching and (2) propensity weighting. For the matching procedure, we matched a treated subject to an untreated subject by using one-to-one nearest neighbour matching without replacement and 0.1 caliper distance on the logit scale. In the propensity weighting, the so-called inverse probability weighting, treated subjects are weighted by *1/propensity score*, and untreated subjects are weighted by *1/(1 *− *propensity score)*. Note that causal effects estimated by propensity matching and propensity weighting are different from each other. The matching estimates the average treatment effect in the *treated population*, while the weighting method estimates the average treatment effect in the *total population*. For handling missing values, we applied following four different methods.

### Complete case analysis {#Sec7}

In this approach, only observations with complete information are used for analysis.

### Missing indicator method {#Sec8}

When a covariate contains missing values, they were replaced by one single value, for example by the value 0. Additionally, a missing indicator variable was created with the value 1 indicating that the corresponding value is missing and the value 0 indicating that it is observed. The missing indicator variable was then added as a covariate in a propensity score model. When there are multiple covariates with missing values, missing indicators will be created for each covariate which will be all added to a propensity score model.

### Multiple imputation {#Sec9}

The third method considered was multiple imputation. Here the chained equation (MICE) procedure, a commonly used imputation method that assumes data are missing at random \[[@CR25]\], was used. We used the default options of MICE version 3.3.0 \[[@CR26]\] in R version 3.5.1: predictive mean matching via a regression model with main effects of X~1~, X~2~, T and with or without Y. In this way, the simulations reflect how most applied researchers using R would perform multiple imputation. Predictive mean matching is also readily available in SAS version 9.4, Stata version 15 and IBM SPSS version 25.0, and it is recommended when data contains both continuous and discrete values \[[@CR27], [@CR28]\]. As a sensitivity analysis we repeated Simulation setting 2 by using MICE with Bayesian linear regression, since many researchers will opt for this method when covariates and outcomes are continuous.

In Simulation setting 2, where a heterogeneous treatment effect exists, we additionally used a more extensive imputation model with three interaction terms included; the interaction between T and X~1~, T and Y, and X~1~ and Y. Adding interaction terms between the variables in an multiple imputation regression model is advocated by Tilling et al. \[[@CR29]\]. For every multiple imputation, ten imputed datasets were generated. A treatment effect was estimated within each imputed dataset using the propensity score methods. Using Rubin's rule, the ten treatment effects were then combined into a single treatment effect. This method is referred to as the within method \[[@CR30]\].

We explored whether the outcome should be included in the imputation model. The idea behind the propensity score methods is that the probability of receiving the treatment is modelled without knowing the outcome \[[@CR16]\], which is why some researchers argue that the outcome should not be used in the imputation model \[[@CR31]\]. The purpose of multiple imputation, however, is a reconstruction of data to retain the original relationship between the covariates as much as possible, for which the outcome could provide valuable information \[[@CR32]--[@CR35]\]. This suggests that the outcome should be added in an imputation model.

### Multiple imputation together with missing indicator {#Sec10}

The fourth method was a combination of multiple imputation and the missing indicator method. Multiple imputation was used to impute the missing values. Afterward, both the imputed covariate and a missing indicator variable were added in the propensity score model \[[@CR36]\]. Multiple imputation was performed following the same procedure as in Sect. [2.4.3](#Sec9){ref-type="sec"}, where the treatment effect is estimated by the within method.

Simulation summary {#Sec11}
------------------

Each simulation run generated a thousand observations and was repeated for a thousand times. We summarised the simulation results by calculating the mean treatment effects over the simulations and the standard deviation of the estimated treatment effects. As overall measures of performance, we calculated the mean squared error, which is the squared distance between the estimated treatment effect and the true treatment effect averaged over the simulations.

In Simulation setting 1 and 3, the true treatment effect was null for all subjects, which means that the mean estimated treatment effects deviating from 0 demonstrates bias has been introduced. In Simulation setting 2, the average treatment effect in the *population*; the causal effect estimated by propensity weighting, was also equal to null. However, due to the heterogeneous treatment effect, the average treatment effect in the *treated*; the causal effect estimated by propensity matching, differed from null. In this simulation setting, the treatment effect for individual *i* is equal to X~2*i*~ which implies the average treatment effect in the treated would be E\[X~2~\|T = 1\]. In this simulated example E\[X~2~\|T = 1\] was equal to 0.432.

Results {#Sec12}
=======

Simulation setting 1: No unmeasured confounding and a homogeneous treatment effect {#Sec13}
----------------------------------------------------------------------------------

Figure [4](#Fig4){ref-type="fig"} (left) displays the mean estimated effects of the propensity weighting analysis in Simulation setting 1 and their 5th and 95th percentile range. Table [1](#Tab1){ref-type="table"} shows the mean estimates with standard deviations and mean squared errors from the propensity matching and the propensity weighting. Complete case analysis yielded unbiased treatment effect estimates in all scenarios, even when data were missing not at random. The missing indicator method alone resulted in biased estimates in all scenarios. The results suggested that the outcome should be included in an imputation model, since the imputation models not including the outcome resulted in bias. In the MCAR and MAR scenario, multiple imputation including the outcome yielded the smallest mean squared errors, and combining multiple imputation and missing indicator method worked as efficient. In the MNAR scenario, combining multiple imputation and missing indicator method was slightly less biased than multiple imputation alone.Fig. 4Mean treatment effects and their 5th and 95th percentile ranges estimated by propensity weighting in Simulation setting 1 (left), 2 (middle) and 3 (right). For each missing scenario, missing data are handled with complete case analysis, missing indicator method, multiple imputation, and the combination of multiple imputation and missing indicator method (Combined method). The vertical lines represent the true treatment effectTable 1Results of treatment effect estimates from propensity matching and propensity weighting when assuming there is a homogeneous treatment effect and no unmeasured confounding. For each missing scenario, missing data are handled with complete case analysis, missing indicator method, multiple imputation, and the combination of multiple imputation and missing indicator (Combined method)Homogeneous treatment effectPropensity matchingPropensity weightingCoefficientMSECoefficientMSEMeanSDMeanSDNo missingNo adjustment1.2980.1231.7001.2980.1231.700After adjustment0.0440.0850.0090.0060.1090.012MCARComplete case analysis0.0430.1210.0160.0140.1520.023Missing indicator0.2380.0950.0660.1890.1110.048Multiple imputation With Y0.0470.0860.0100.0110.1130.013 Without Y0.2190.0870.0560.1860.1100.047Combined method With Y0.0480.0870.0100.0110.1120.013 Without Y0.2180.0870.0550.1870.1100.047MARComplete case analysis0.0240.1280.0170.0070.1650.027Missing indicator0.2590.0990.0770.1720.1230.044Multiple imputation With Y0.0520.0920.0110.0100.1220.015 Without Y0.2440.0900.0680.1850.1200.049Combined method With Y0.0500.0920.0110.0100.1220.015 Without Y0.2430.0900.0670.1850.1200.048MNARComplete case analysis0.0250.1290.0170.0120.1660.028Missing indicator0.2310.0980.0630.1490.1220.037Multiple imputation With Y0.0690.0950.0140.0290.1230.016 Without Y0.2480.0910.0700.2150.1180.060Combined method With Y0.0520.0930.0110.0110.1220.015 Without Y0.2110.0880.0530.1600.1190.040

Simulation setting 2: No unmeasured confounding and a heterogeneous treatment effect {#Sec14}
------------------------------------------------------------------------------------

Figure [4](#Fig4){ref-type="fig"} (middle) visualises the results of the propensity weighting analysis of Simulation setting 2, and Table [2](#Tab2){ref-type="table"} summarises the results of the propensity matching and the propensity weighting. Here the complete case analysis yielded negatively biased results in the MAR or MNAR scenarios. This is because the subjects with higher X~2~ values, for whom the treatment was most beneficial, had higher probabilities to be excluded in the analyses. The missing indicator method was still biased in all scenarios. The amount of bias, however, was relatively small in the MNAR scenario. We observed a remarkable result in the MAR scenario: the default multiple imputation method yielded biased effect estimates, even when the outcome was included in the imputation model and when a missing indicator was added to the propensity model. When more elaborate imputation regression models with specified interaction terms were used, the bias from the propensity weighting was much smaller, although a slight bias still remained (0.013).Table 2Results of treatment effect estimates from propensity matching and propensity weighting when assuming X~2~ is an effect modifier and no unmeasured confounder exists. Here, multiple imputation is done in two ways; commonly used method (no interaction term) and elaborated method (interaction terms included)Heterogeneous treatment effectPropensity matchingPropensity weightingCoefficientBiasMSECoefficientMSEMeanSDMeanSDNo missingNo adjustment1.7360.1561.4092.0111.7360.1563.040After adjustment0.3270.0930.0000.009− 0.0030.1520.023MCARComplete case analysis0.3000.133− 0.0270.018− 0.0030.2190.048Missing indicator0.5740.1200.2470.0750.3050.1620.119*No interaction term*Multiple imputation With Y0.3150.103− 0.0120.011− 0.0210.1680.029 Without Y0.5420.1080.2150.0580.2970.1580.113Combined method With Y0.3150.102− 0.0120.011− 0.0210.1690.029 Without Y0.5410.1100.2140.0580.2970.1580.113Interaction terms Multiple imputation0.3160.103− 0.0110.011− 0.0020.1660.028 Combined method0.3160.104− 0.0110.011− 0.0030.1660.028MARComplete case analysis0.1290.147− 0.1980.061− 0.2000.2410.098Missing indicator0.6200.1220.2930.1010.2720.1790.106*No interaction term*Multiple imputation With Y0.2510.107− 0.0760.017− 0.0930.1810.042 Without Y0.5790.1120.2520.0760.2860.1730.111Combined method With Y0.2500.108− 0.0770.017− 0.0920.1820.042 Without Y0.5800.1130.2530.0770.2850.1730.111Interaction terms Multiple imputation0.3300.1160.0030.0130.0100.1850.034 Combined method0.3300.1160.0030.0130.0100.1850.034MNARComplete case analysis− 0.1110.141− 0.4380.211− 0.4110.2240.219Missing indicator0.5880.1210.2610.0820.2300.1710.082*No interaction term*Multiple imputation With Y0.1510.114− 0.1760.044− 0.2380.2070.100 Without Y0.5860.1120.2590.0800.3500.1650.150Combined method With Y0.1400.111− 0.1870.047− 0.2480.2060.104 Without Y0.5460.1080.2190.0600.2480.1650.089Interaction terms Multiple imputation0.1820.117− 0.1450.035− 0.1920.2080.080 Combined method0.1700.114− 0.1570.038− 0.2050.2640.112

The results of propensity matching even in the situation without any missing values (0.327) deviated from the treatment effect in all treated subjects (0.432). This discrepancy is a general problem of propensity score matching \[[@CR37]--[@CR39]\]. A large caliper distance allows treated subjects with high propensity scores to be matched to untreated subjects with lower propensity scores, which will result in residual confounding. A smaller caliper distance reduces the confounding bias. However, many subjects, especially the subjects with high propensity score, may not be matched. Therefore, the treatment effect in the treated *who are matched* may deviate from the treatment effect in *all* treated. The size of this discrepancy depends on the heterogeneity of the treatment effect. In this simulation setting, we used matching without replacement with a caliper distance of 0.1, which allows rather tight matching. Thus, for some of the treated subjects with high propensity score, whose treatment effect was more effective, no adequate untreated match could be found. As we were specifically interested in the additional bias under the different missing mechanisms, we used the estimate of propensity matching without any missing data (0.327) as a reference. Once more, we observed that multiple imputation with interaction terms performed best as it did in propensity weighting analysis.

The results of multiple imputation with Bayesian regression methods done in a sensitivity analysis did not largely differ from the results of predictive mean matching (see Appendix [1](#Sec22){ref-type="sec"}, for the results in Simulation setting 2).

Simulation setting 3: Unmeasured confounding and a homogeneous treatment effect {#Sec15}
-------------------------------------------------------------------------------

Figure [4](#Fig4){ref-type="fig"} (right) displays the results of the propensity weighting of Simulation setting 3, and Table [3](#Tab3){ref-type="table"} summarises the results of propensity matching and propensity weighting. Due to the unmeasured confounder U, bias remained in the propensity analyses even when there were no missing values. In the MNAR scenario where the missingness of X~2~ depends on U, two methods were able to reduce the unmeasured confounding effect: the combined method and, somewhat surprising, the complete case analysis. The combined method partially adjusted for U by adding R to the propensity model; the complete case analysis used restriction to partially adjust for U, using only those with complete data. The results here were substantially less biased than the propensity analyses performed in complete data without missing values.Table 3Results of treatment effect estimates from propensity matching and inverse probability weighting, when an unmeasured confounding existsHomogeneous treatment effect/unmeasured confoundingPropensity matchingPropensity weightingCoefficientMSECoefficientMSEMeanSDMeanSDNo missingNo adjustment2.0110.1544.0682.0110.1544.068After adjustment0.3770.1110.1540.3280.1680.136MCARComplete case analysis0.3620.1520.1540.3360.2330.167Missing indicator0.8700.1380.7760.7740.1710.628Multiple imputation With Y0.3760.1190.1550.3300.1710.138 Without Y0.8070.1190.6650.7710.1650.621Combined method With Y0.3750.1190.1550.3300.1710.138 Without Y0.8080.1190.6670.7700.1650.620MNARComplete case analysis0.1450.1630.0480.1570.2550.089Missing indicator0.5140.1170.2770.3450.1970.158Multiple imputation With Y0.4220.1410.1970.3540.2000.165 Without Y1.0030.1291.0231.0280.1541.079Combined method With Y0.2400.1140.0710.1690.1910.065 Without Y0.4690.1050.2310.3860.1750.180

Guidance for the optimal strategy to handle missing values in baseline covariates in the context of propensity score analysis {#Sec16}
=============================================================================================================================

The aim of a propensity score analysis is to obtain an average treatment effect in a certain population. To explain, we use the following notation in which every subject can have two potential outcomes:Y^1^; the outcome if the person receives treatment 1.Y^0^; the outcome if the person receives treatment 0.

Propensity weighting aims to estimate the average treatment effect in the *whole population* (ATE), which is equal to: $\documentclass[12pt]{minimal}
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                \begin{document}$$ATE = E\left[ {Y^{1} - Y^{0} } \right].$$\end{document}$ With propensity matching, where treated subjects are matched to untreated subjects, the aim is to estimate the average treatment effect in the *treated population* (ATT): $\documentclass[12pt]{minimal}
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                \begin{document}$$ATT = E\left[ {Y^{1} - Y^{0} |{\text{T}} = 1} \right].$$\end{document}$ Several standard causal inference conditions such as exchangeability, consistency and positivity should hold to be able to estimate these causal effects without bias \[[@CR40]\]. Whether the unbiased causal effects can still be estimated when missing values are present in the covariates of a propensity score depends on several elements: type of missingness, presence of effect modification and the population of interest. In the following section, we discuss under which criteria the four methods dealing with missing values will yield valid causal treatment effect in the context of propensity score analysis.

Complete case analysis, when does it work? {#Sec17}
------------------------------------------

When there is no unmeasured confounding and the propensity score model is well specified, propensity weighting using complete cases will yield a valid estimate of a causal treatment effect, which will be the causal treatment effect in the *subjects without missing values:*$$\documentclass[12pt]{minimal}
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                \begin{document}$$E\left[ {Y^{1} - Y^{0} | R = 0} \right]$$\end{document}$$This means that propensity weighting using complete case analysis will yield valid estimates of the ATE in the population when the mean treatment effect in the fully observed subjects is equal to that of the subjects with missing values. That is:$$\documentclass[12pt]{minimal}
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When no effect modification and no unmeasured confounding is present, condition ([1](#Equ1){ref-type=""}) will also hold since the treatment effect in the total population will be equal to the treatment effect in any subgroup regardless of the missing mechanism of data. This was the case in Simulation 1 where the effect of the treatment was constant across subjects. In this scenario, the complete case analysis yielded unbiased results even when the missing was not at random. Analogous arguments can be given for propensity matching using complete cases. The propensity matching will yield valid estimates if:$$\documentclass[12pt]{minimal}
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Even when there is unmeasured confounding, complete case analysis may be a useful way to handle missing values. Think of a situation where the severity of a disease determines whether certain laboratory tests will be performed. Severity of disease here may be an unmeasured confounder, which determines the values of observed covariates (in this case the laboratory measurements) to be missing. This is a comparable situation to the MNAR scenario of Simulation setting 3. Here, the complete case analysis yielded less biased results, because by restricting the analysis to subjects with R = 0 (only the subjects with the severe diseases who therefore have all lab measurements), the results are partially adjusted for the unmeasured confounder.

Missing indicator, when does it work? {#Sec18}
-------------------------------------

In general, we do not recommend to solely use the missing indicator method for handling missing values in confounders. The method is prone to result in bias because the information of the missing portion of the covariates is replaced by a dichotomous missing indicator R, consequently resulting in residual confounding. However, when data are missing not at random and the covariate with missing value is strongly associated to its missing indicator, the missing indicator variable in a propensity model may yield smaller bias than the model without it. This was the case in the MNAR scenarios of Simulation setting 1 and 2. Similarly, when the missing of X~2~ is strongly related to an unmeasured confounder U, the partial effect of U can be recovered by adding R in the propensity model. This was seen in the MNAR scenario of Simulation 3.

Multiple imputation, when does it work? {#Sec19}
---------------------------------------

The aim of multiple imputation is to recover the joint distribution of covariates, treatment and outcome by reconstructing the missing values using the information from observed data. When there is no unmeasured confounding, multiple imputation in the context of propensity score analysis will be a valid approach under the following conditions:Data are missing at random or completely at random, meaning that the missing values are *recoverable* from the observed data. M-graphs can be used to visually determine whether the missing mechanism is at random. In m-graphs, the missing at random mechanism means that all paths between a covariate with missing values and its missing indicator can be blocked by conditioning on measured variables. In DAG terms, it is said; two variables are *d*-*separated*. In our study, this was the case in Figs. [1](#Fig1){ref-type="fig"}a, b and [2](#Fig2){ref-type="fig"}a, b. Note that in Figs. [1](#Fig1){ref-type="fig"}b and [2](#Fig2){ref-type="fig"}b, the path between X~2~ and R can be blocked by conditioning on X~1~.An imputation model should be correctly specified. This requires that:the outcome should be included in the imputation model.interaction terms between the covariates, treatment and outcome should be included in the imputation model if a heterogeneous treatment effect is present.

In Simulation setting 1, multiple imputation yielded unbiased results even though it was used to impute a non-recoverable X~2~. Note that the reason why multiple imputation worked well in this scenario was because 1) the covariates, treatment and the outcome in the model were linearly related, and 2) missing values in X~2~ were generated probabilistically which means the information of higher X~2~ values could be gained from the data. This result is due to the simulation scenario we generated and should not be taken to show that multiple imputation can be used when data are missing not at random.

What to do in situations where complete case analysis or multiple imputation fails? {#Sec20}
-----------------------------------------------------------------------------------

We saw in the previous section it is important that a researcher is aware of the missing mechanism and whether strong heterogeneity is present. Depending on the missing mechanism and the heterogeneity in the treatment effect, both complete case analysis and multiple imputation may fail. Whether the treatment effect is heterogeneous can be explored by subgroup analysis and comparing the estimated effects across the groups. When there is large difference across the subgroups, interaction terms should be specified in the multiple imputation. This was shown in Simulation setting 2.

The missing mechanism behind the data can be explored by drawing the expected causal structure and missing structure in a m-graph. When complete case analysis and multiple imputation are expected to fail, the combination of multiple imputation and the missing indicator method could be used to partially recover the effect of missing portions of covariates. For example, in the MNAR scenario of Simulation setting 3, the combined approach performed better than multiple imputation alone and even better than the analysis on the data without any missing values. When the relation between R and U is stronger, more of the effect of the unmeasured confounder will be recovered.

Discussion {#Sec21}
==========

Our simulations showed that there is no single method to handle missing values in covariates of a propensity score model which would perform optimally in all situations. The optimal strategy depends on the missing data structure and whether there is effect modification or unmeasured confounding. We focussed on missing values in covariates, because in routinely collected data baseline patient characteristics are often incomplete while prescribed treatments and important outcomes of patients will be more generally recorded.

Our results cannot be generalized to the situations when there are missing values in the treatment assignment or the outcome. An example of this is that under homogenous treatment effect and no unmeasured confounding, complete case analysis will yield biased results if the outcome is missing not at random.

Propensity score analysis mimics randomized control studies by creating conditional exchangeability between the subjects with the same propensity score. Both propensity weighting and matching aim to obtain valid estimates of marginal treatment effects. This is different from outcome regression analysis which estimates conditional treatment effects. Unlike outcome regression model, no assumptions about treatment-outcome relation and the effect of the confounders on the outcome have to be made in propensity score analysis; only the propensity score model has to be correctly specified. This is an advantage, especially when the outcome is rare in which case fitting an extensive outcome model is not possible.

When using multiple imputation, the advantage of not having to formulate a treatment-outcome relation model disappears. In our simulations we showed that all variables associated with the covariates with missing values, including the outcome, should be included in the imputation model. Furthermore, when effect modification is present, the interaction terms between the variables should be correctly specified in the imputation model as well. The results correspond to the idea that imputation models should reflect the complexity of the data analysis procedure \[[@CR41], [@CR42]\]. When complex modelling is needed for multiple imputation, an alternative to propensity score analysis could be to use an outcome regression model with specified interaction terms. By fitting this outcome regression model, one can predict potential outcomes under treatment and no treatment for *every individual*. Then, the *average* potential outcomes can be estimated by integrating over the covariate distribution, and used to obtain the average treatment effect in the population \[[@CR40]\].

Multiple imputation is not a panacea to handle missing values, and should be used more consciously. In our simulations we demonstrated that a default option for multiple imputation in commonly used software such as SAS, Stata, SPSS or R yielded biased results (based on Simulation setting 2) even when data were missing at random and no unmeasured confounding was present.

Complete case analysis may often be a good method to deal with missing values in covariates. Although statistical efficiency is lost, estimated effects still have a causal interpretation if there is no unmeasured confounding. In these cases, it is up to the researcher to determine how generalizable these results are to the general population of interest. In the case of substantial heterogeneity of treatment effects, generalizability cannot be taken for granted.

When unmeasured confounding is present, all standard missing data methods fail to provide valid estimates. Complete case analysis, however, may reduce the bias by controlling the unmeasured confounding by restriction. The use of an indicator variable (with or without multiple imputation) may also reduce the bias, because the indicator variable functions as a proxy for the unmeasured confounding.

A recent systematic review on how missing data are addressed with propensity score methods in observational comparative effectiveness studies showed that among 167 studies conducted from 2010 to 2017, only 86 (51%) discussed missing data issues and only 12 (7%) provided reasons for missingnesss \[[@CR43]\]. Our simulation study showed that it is important to make assumptions about the expected relationship between the unobserved and observed covariates. This allows one to understand the expected missing structure of the data and to handle missing values more cautiously. We recommend researchers to use m-graphs to draw their assumption between the covariates and their missing indicator explicitly. In summary, in the context of propensity score analysis we urge researchers to consciously choose missing data strategies while considering the missing data mechanisms, possible unmeasured confounding and heterogeneity of treatment effects.

Appendix {#Sec22}
========

See Table [4](#Tab4){ref-type="table"}.Table 4Results of Simulation setting 2 where the multiple imputation by chained equations (MICE) with Bayesian linear regression is used  for a sensitivity analysisHeterogeneous treatment effectPropensity matchingPropensity weightingCoefficientBiasMSECoefficientMSEMeanSDMeanSDNo adjustment1.7300.1581.4102.0121.7300.1583.019After adjustment0.3210.0960.0000.009− 0.0170.1560.025*No interaction term*Multiple imputation With Y0.3040.095− 0.0170.009− 0.0410.1700.031 Without Y0.5360.1010.2150.0560.2920.1420.105Combined method With Y0.3030.095− 0.0180.009− 0.0420.1720.031 Without Y0.5370.1040.2160.0580.2940.1430.107Interaction terms Multiple imputation0.3150.094− 0.0060.009− 0.0140.1690.029 Combined method0.3150.096− 0.0060.009− 0.0150.1710.029*No interaction term*Multiple imputation With Y0.2200.103− 0.1010.021− 0.1160.1920.050 Without Y0.5680.1100.2470.0730.2640.1580.095Combined method With Y0.2200.1010.010− 0.1160.1900.049 Without Y0.5680.1110.2480.0740.2640.1570.094Interaction terms Multiple imputation0.3300.1010.0090.0100.0020.1990.040 Combined method0.3310.1030.0100.0110.0010.1980.039*No interaction term*Multiple imputation With Y0.1020.110− 0.2190.060− 0.2690.2130.118 Without Y0.5700.1100.2490.0740.3250.1530.129Combined method With Y0.0950.103− 0.2250.061− 0.2750.2110.120 Without Y0.5370.1050.2160.0580.2330.1490.076Interaction terms Multiple imputation0.1730.101− 0.1470.032− 0.1970.2200.087 Combined method0.1690.103− 0.1510.034− 0.2060.2150.089
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